A phospholipidomic analysis of all defined human plasma lipoproteins

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Dashti, Monireh ^a   Kulik, Willem ^b   Hoek, Frans ^c   Veerman, Enno C ^d   Peppelenbosch, Maikel P ^a,e   Rezaee, Farhad ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Laboratory Genetic Metabolic Diseases   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; SPHINGOMYELIN;

ARTICLE; BLOOD; CHEMISTRY; CLASSIFICATION; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; PHOSPHORYLATION; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY;

CHROMATOGRAPHY, THIN LAYER; HUMANS; LIPOPROTEINS; LYSOPHOSPHATIDYLCHOLINES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPIDS; PHOSPHORYLATION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOMYELINS; TANDEM MASS SPECTROMETRY;

EID: 84859739231     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00139     Document Type: Article

References (62)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362, 801-809 (1993). (Pubitemid 23132154)
2. Berliner, J. A., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91, 2488-2496 (1995).
3. Castelli, W. P., Garrison, R. J., Wilson, P. W. Abbott, R. D., Kalousdian, S. & Kannel, W. B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256, 2835-2838 (1986). (Pubitemid 17178361)
4. Atkinson, D. & Small, D. M. Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biochem 15, 403-456 (1986).
5. Mahley, R. W. Innerarity TL, Rall SC, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res 25, 1277-1288 (1984).
6. Davidson, W. S., Sparks, D. L., Lund-Katz, S. & Phillips MC. The molecular basis for the difference in charge between pre-beta-and alpha-migrating high density lipoproteins. J Biol Chem 269, 8959-65 (1994).
7. Cushley, R. J. & Okon, M. NMR studies of lipoprotein structure. Annu. Rev Biophys Biomol Struct 31, 177-206 (2002). (Pubitemid 34666830)
8. Tollefson, J. H., Ravnik, S. & Albers, J. J. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res 29, 1593-1602 (1988). (Pubitemid 19030527)
9. Tall, A. R., Krumholz, S., Olivecrona, T. & Deckelbaum, R. J. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J Lipid Res 26, 842-851 (1985). (Pubitemid 15046448)
10. Tu, A. Y., Nishida, H. I. & Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 268, 23098-231059 (1993).
11. Wolfbauer, G., Albers, J. J. & Oram, J. F. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high density lipoprotein apolipoproteins. Biochim Biophys Acta 143, 965-76 (1999).
12. Bagdade, J. D., Buchanan, W. F., Pollare, T. & Lithell H. Abnormal lipoprotein phospholipid composition in patients with essential hypertension. Atherosclerosis 117, 209-215 (1995).
13. Yancey, P. G., et al. In vivo modulation of HDL phospholipid has opposing effects on SR-BI-and ABCA1-mediated cholesterol efflux. J Lipid Res 45, 337-346 (2004). (Pubitemid 38228832)
14. Yancey, P. G., et al. High density lipoprotein phospholipid composition is amajor determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem 275, 36596-36604 (2000). (Pubitemid 32002059)
15. Baker, P. W., Rye, K. A., Gamble, J. R., Vadas, M. A. & Barter, P. J. B. vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid. Res 40, 345-353 (1999).
16. Baker, P. W., Rye, K., Gamble, J. R., Vadas, M. A. & Barter, P. B. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J Lipid Res 41, 1261-1267 (2000). (Pubitemid 30666892)
17. Subbaiah, P. V. & Pritchard, P. H. Molecular species of phosphatidylcholine in familial lecithin-cholesterol acyltransferase deficiency: effect of enzyme supplementation. Biochim Biophys Acta 1003, 145-150 (1989). (Pubitemid 19145430)
18. Ashby, D., et al. Lack of effect of serum amyloid A (SAA) on the ability of highdensity lipoproteins to inhibit endothelial cell adhesion molecule expression. Atherosclerosis 154, 113-121 (2001). (Pubitemid 32008570)
19. Fournier, N., et al. HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum. Arterioscler. Thrombo Vasc Biol 17, 2685-2691 (1997). (Pubitemid 28016009)
20. Xia, P., Vadas, M. A, Xia, P., Vadas, M. A, Rye, K. A., Barter, P. J. & Gamble JR. High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway: A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem 274, 33143-33147 (1999). (Pubitemid 129535357)
21. Piperi, C., Kalofoutis, C., Tzivras, M., Troupis, T., Skenderis, A. & Kalofoutis, A. Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients. Mol. Cell Biochem 265, 57-61 (2004). (Pubitemid 41461864)
22. Pruzanskia, W., Stefanski, E., de Beer, F. C., de Beer, M. C., Ravandi, A. & Kuksis, A. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J Lipid Res 41, 1035-047 (2000). (Pubitemid 30483006)
23. Van Lenten, B. J., et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell co cultures. J Clin Invest 96, 2758-2767 (1995).
24. Ibdah, J. A, Lund-Katz, S. & Philips, M. C. Molecular packing of high-density and low-density lipoprotein surface lipids and apolipoprotein A-I binding. Biochemistry 28, 1126-33 (1989).
25. Verkade, H. J., Fast, D. G., Rusinol, A. E., Scraba, D. G. & Vance, D. E. Impaired biosynthesis of phosphatidylcholine causes a decrease in the number of very low density lipoprotein particles in the Golgi but not in the endoplasmic reticulum of rat liver J Biol Chem 268, 24990-24996 (1993). (Pubitemid 23335519)
26. Fast, D. G., Fast, D. G., Vance, D. E. Nascent, M. VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion. Biochim Biophys Acta 1258, 159-168 (1995).
27. Klein, S., Spannagl, M. & Engelmann, B. Phosphatidylethanolamine Participates in the Stimulation of the Contact System of Coagulation by Very-Low-Density Lipoproteins. Arterioscler Thrombo Vasc Biol 21, 1695-1700 (2001). (Pubitemid 34215593)
28. Navab M, Hama S, Hough G, Fogelman AM. Oral synthetic phospholipids (DMPC) raise high-density lipoprotein cholesterol levels, improve high-density lipoprotein function, and markedly reduce atherosclerosis in apolipoprotein Enull mice. Circulation 108, 1735-1739 (2003). (Pubitemid 37243663)
29. Burgess, J. W., Neville, T. A. M., Rouillard, P., Harder, Z., Beanlands, D. S. & Sparks DL. Phosphatidylinositol increases HDL-C levels in humans. J Lipid Res 46, 350-355 (2005). (Pubitemid 40271099)
30. Stamler, C. J., Breznan, D., Neville, T. A., Viau, F. J., Stamler, C. J., Breznan, D., Neville, T. A., Viau, F. J., Camlioglu, E. & Sparks DL. Phosphatidylinositol promotes cholesterol transport in vivo. J Lipid Res 41, 1214-1221 (2000). (Pubitemid 30666886)
31. Burgess, J. W., et al. Phosphatidylinositol promotes cholesterol transport and excretion. J Lipid Res 44, 1355-1363 (2000).
32. Rezaee, F., Casetta, B., Levels, J. H. M., Speijer, D. & Meijers, J. C. M. Proteomic analysis of high-density lipoprotein. Proteomics 2, 721-730 (2006). (Pubitemid 43208050)
33. Queiroz, K. C., et al. Human PlasmaVery LowDensity Lipoprotein Carries Indian Hedgehog. J Proteome RES 9, 5052-5059 (2010).
34. Kleinveld, H. A., Duif, P. F. & Kleinveld, H. A., Duif, P. F. & Pekelharing, H. L. Oxidation of lipoprotein(a) and low density lipoprotein containing density gradient ultracentrifugation fractions. Biochim Biophys Acta 1303, 15-21 (1996). (Pubitemid 26308532)
35. Levels, J. H. M., Abraham, P. R., van den Ende, A., van Deventer, S. J. H. Distribution and Kinetics of Lipoprotein-Bound End. Infect Immune 68, 2821-2828 (2001).
36. Weerheim, A. M., Kolb, A. M., Sturk, A. & Nieuwland, R. Phospholipid Composition of Cell-Derived Microparticles Determined by One-Dimensional High-Performance Thin-Layer Chromatography. Analy Biochem 302, 191-198 (2002). (Pubitemid 34229723)
37. Sachinidis, A., et al. Evidence that lipoproteins are carriers of bioactive factors. Arterioscler. Thromb Vasc Biol 19, 2412-2421 (1999). (Pubitemid 29477843)
38. Nofer, J. R., et al. Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids. J Biol Chem 276, 34480-34485 (2001).
39. Deguchi, H., Fernandez, J. A., Hackeng, T. M., Banka, C. L. & Griffin, J. H. Cardiolipin is a normal component of human plasma lipoproteins. Proc Natl Acad Sci USA 97, 1743-1748 (2000). (Pubitemid 30118513)
40. Schwarz, H. P., Dahike, M. B. and Dreisbach, L. Phospholipid composition of blood plasma, Erythrocytes and "Ghosts" in Sickle Cell Disease. CLIN CHEM 23, 1548-1550 (1977). (Pubitemid 8178037)
41. Uran, S., smund, A., Petter, L., Jacobsen, B. and Skotland, T. Analysis of phospholipid species in human blood using normal-phase liquid chromatography coupled with electrospray ionization ion-trap tandem mass spectrometry. J of Chromato B 758, 265-275 (2001). (Pubitemid 32524022)
42. Castelli, W. P. Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study. Can J Cardiol 4 Suppl A 5A-10A (1988).
43. Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B. & Dawber, T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62, 707-714 (1997).
44. Papasani, V. S., Veedamali, S. S. & Kewei, W. Novel Physiological Function of Sphingomyelin in Plasma. Inhibition of lipid peroxidation in Low-density lipoproteins. J Biol Chem 274, 36409-36414 (1999).
45. Rye, K. A., Hime, N. J. & Barter, P. J. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J Biol Chem 271, 4243-4250 (1996).
46. Arimoto, I., Saito, H., Kawashima, J. K., Miyajima, K. & Handa, T. Effect of cholesterol on apolipoprotein A-I binding to lipid bilayers and emulsions. J Lipid Res 38, 287-294 (1997). (Pubitemid 27118041)
47. Arimoto, I., Saito, H., Kawashima, J., Miyajima, K. & Handa, T. Effects of Sphingomyelin and Cholesterol on Lipoprotein Lipase-Mediated Lipolysis in Lipid Emulsions. J Lipid Res 39, 143-151 (1998). (Pubitemid 28063550)
48. Schlitt, A., et al. Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles. J Lipid Res 46, 196-200 (2005). (Pubitemid 40271082)
49. Xian-cheng, H. et al. Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease. Arterioscler. Thromb Vasc Biol 20, 2614-2618 (2000).
50. Vaysse, J., Pilardeau, P. & Garnier, M. Rapid quantitative analysis of phospholipids in biological fluids after thin-layer chromatography. Clin Chim Acta 147, 183-190 (1985). (Pubitemid 15090101)
51. Agren, J. J., Kurvinen, J. P. & Kuksis, A. Isolation of very low density lipoprotein phospholipids enriched in ethanolamine phospholipids from rats injected with Triton WR 1339. Biochim Biophys Acta 1734, 34-43 (2005). (Pubitemid 40615218)
52. Dennis, M. W., Downey, C., Brufatto, N., Nesheim, M. E., Stevenson, K., & Toh CH. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein. Thromb Haemost 915, 22-530 (2004).
53. Noga, A. A., Zhao, Y. & Vance, D. E. An Unexpected Requirement for Phosphatidylethanolamine N-Methyltransferase in the Secretion of Very Low Density Lipoproteins. J Biol Chem 277, 42358-42365 (2002). (Pubitemid 35257557)
54. Parthasarathy, S., Steinbrecher, U. P., Barnett, J., Witztum, J. L. & Steinberg D. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82, 3000-3004 (1985). (Pubitemid 15097780)
55. Portman, O. W. & Alexander, M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res 101, 58-65 (1969).
56. Masakazu, K., et al. Induction by Lysophosphatidylcholine, a Major Phospholipid Component of Atherogenic Lipoproteins, of Human Coronary Artery Smooth Muscle Cell Migration. Circulation 983, 53-359 (1998).
57. Noriaki, Y., et al. Lyso-phosphatidylcholine phosphorylates CREB and activates the jun2TRE site of c-jun promoter in vascular endothelial cells. FEBS LETT 457, 241-245 (1999).
58. Houtkooper, R. H. et al. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal Biochem 387, 230-237 (2009).
59. Taguchi, R. et al. Focused lipidomics by tandem mass spectrometry. J of Chromato B 823, 26-36 (2005). (Pubitemid 41073986)
60. Sommer, U., Herscovitz, H., Welty, F. K. and Costello, C. E. LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J Lipid Res 47, 804-814 (2006).
61. Cole, M. J. & Enke, C. G. Direct Determination of Phospholipid Structures in Microorganisms by Fast Atom Bombardment Triple Quadrupole Mass Spectrometry. Anal Chem 63, 1032-1038 (1991).
62. Han, X. et al. Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples. J Lipid Res 47, 864-879 (2006).